Status:

NOT_YET_RECRUITING

Intercostal Mulligan Moblization Post Mastectomy

Lead Sponsor:

Cairo University

Conditions:

Post Mastectomy Complications

Eligibility:

All Genders

40-60 years

Phase:

NA

Brief Summary

the study is to evaluate the therapeutic efficacy of intercostal mulligan Mobilization in decreasing pain and improve ROM for shoulder dysfunction Patients post mastectomy.

Eligibility Criteria

Inclusion

  • Patients post modified radical mastectomy at least 3 months prior and had a limited ROM in abduction.
  • Patients post mastectomy with lateral chest wall pain.
  • Age ranges between 40-60 years.
  • All patients had informed written consent

Exclusion

  • Receiving any previous rehabilitation programs for the upper extremities
  • The presence of any type of metastases
  • The presence of lymphedema
  • Bilateral breast cancer surgery
  • Locoregional recurrence
  • Withdrawal of the consent at any time during the study for any reason

Key Trial Info

Start Date :

September 16 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 16 2026

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT07181980

Start Date

September 16 2025

End Date

September 16 2026

Last Update

September 19 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cario U

Cairo, Egypt

Intercostal Mulligan Moblization Post Mastectomy | DecenTrialz